Shares of National Health Investors, Inc. (NYSE:NHI – Get Free Report) have earned an average rating of “Moderate Buy” from the seven research firms that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $73.29.
NHI has been the subject of several analyst reports. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and raised their target price for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Truist Financial lifted their price target on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th. Finally, Bank of America assumed coverage on National Health Investors in a research note on Tuesday, September 24th. They set a “buy” rating and a $92.00 price target for the company.
View Our Latest Stock Analysis on NHI
Institutional Investors Weigh In On National Health Investors
National Health Investors Stock Down 0.2 %
Shares of NYSE NHI opened at $77.71 on Monday. National Health Investors has a 1 year low of $51.59 and a 1 year high of $86.13. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The firm has a market cap of $3.53 billion, a PE ratio of 26.70, a price-to-earnings-growth ratio of 5.20 and a beta of 1.05. The company has a 50 day simple moving average of $79.48 and a 200 day simple moving average of $74.37.
National Health Investors (NYSE:NHI – Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The business had revenue of $63.32 million for the quarter, compared to analyst estimates of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. National Health Investors’s revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.08 EPS. On average, research analysts forecast that National Health Investors will post 4.42 EPS for the current year.
National Health Investors Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.63%. National Health Investors’s dividend payout ratio (DPR) is presently 123.71%.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
- Five stocks we like better than National Health Investors
- Dividend Payout Ratio Calculator
- Tesla Investors Continue to Profit From the Trump Trade
- Investing in Commodities: What Are They? How to Invest in Them
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- What Do S&P 500 Stocks Tell Investors About the Market?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.